These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9260597)

  • 1. First-line chemotherapy of advanced breast cancer with a combination of mitoxantrone, methotrexate, and vincristine (MIMO).
    Samonis G; Bafaloukos D; Margioris AN; Katsarma G; Toloudis P; Bacoyannis C; Karvounis N; Georgoulias V; Kosmidis P
    Oncology; 1997; 54(5):371-5. PubMed ID: 9260597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.
    Bafaloukos D; Samonis G; Klinaki A; Daliani D; Karvounis N; Bacoyiannis C; Karabelis A; Milonakis N; Kosmidis P
    Eur J Cancer; 1993; 29A(6):851-3. PubMed ID: 8484975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
    Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis J; Kalbakis K; Agelaki S; Chalkiadakis G; Sanidas E; Tsiftsis D; Georgoulias V
    Am J Clin Oncol; 1999 Jun; 22(3):273-7. PubMed ID: 10362335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive chemotherapy with cisplatin, mitoxantrone, methotrexate and vincristine in metastatic breast cancer.
    Queirolo P; Repetto L; Gardin G; Miglietta L; Guido T; Pronzato P; Rosso R
    J Chemother; 1991 Jun; 3(3):194-7. PubMed ID: 1919659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy with methotrexate, carboplatin, mitoxantrone (Novantrone) and vincristine (Oncovin) in transitional-cell urothelial cancer.
    Pectasides D; Mylonakis A; Antoniou F; Kostopoulou M; Triantaphyllis D; Papadopoulou M; Varthalitis J; Dimitriadis M; Athanassiou A
    Oncology; 1998; 55(2):139-44. PubMed ID: 9499188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
    Smith IE; Powles TJ
    Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
    Patrone F; Ballestrero A; Ferrando F; Brema F; Moraglio L; Valbonesi M; Basta P; Ghio R; Gobbi M; Sessarego M
    J Clin Oncol; 1995 Apr; 13(4):840-6. PubMed ID: 7707109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line chemotherapy of advanced breast cancer with mitoxantrone, cyclophosphamide and vincristine.
    Bezwoda WR; Dansey R; Seymour L
    Oncology; 1989; 46(4):208-11. PubMed ID: 2740063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
    Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
    J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of mitoxantrone-based combination chemotherapy regimens as first-line treatment for advanced breast cancer.
    Bezwoda WR; Hesdorffer CS; Dansey RD
    S Afr Med J; 1987 Oct; 72(7):465-7. PubMed ID: 3660150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
    Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
    Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone, methotrexate, and 5-fluorouracil combination chemotherapy as first-line treatment in stage IV breast cancer.
    Bezwoda WR; Hesdorffer CS
    Cancer; 1986 Jan; 57(2):218-21. PubMed ID: 3753656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot trial of TMM (thiotepa, mitoxantrone and methotrexate) chemotherapy for metastatic breast cancer.
    Bhardwaj S; Holland JF
    Ann Oncol; 1990 Nov; 1(6):443-4. PubMed ID: 2128030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone, methotrexate and chlorambucil in metastatic breast cancer, a combination with relatively low subjective toxicity.
    Burghouts JT
    Neth J Med; 1990 Feb; 36(1-2):43-5. PubMed ID: 2314519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy with a combination of mitoxantrone, methotrexate, 5-fluorouracil for node-positive breast cancer: phase II pilot study.
    Kanno M; Nakamura S; Uotani C; Taniya T; Mura T; Bando H; Kawahara F; Tsugawa K; Noguchi M
    J Chemother; 1999 Oct; 11(5):396-401. PubMed ID: 10632387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer.
    Smith IE; Stuart-Harris R; Pavlidis N; Bozek T
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():37-40. PubMed ID: 6661733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin (CBDCA), 5-fluorouracil (5-FU) and mitoxantrone (DHAD): an effective and well tolerated regimen for metastatic breast cancer.
    Hidalgo OF; Gonzalez FG; Vieitez JM; Rebollo J; Tangco E; Herranz P
    Ann Oncol; 1992 Jul; 3(7):545-7. PubMed ID: 1498075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma.
    Weaver CH; Greco FA; Hainsworth JD; Zhen B; Baldwin P; Wittlin F; Lewis M; West WH; Schwartzberg L; Buckner CD
    Bone Marrow Transplant; 1997 Nov; 20(10):847-53. PubMed ID: 9404925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.